Edges in Network
| Network | GSE5851_top500tf - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | NEUROG1 |
| Upstream (Parents) |
|---|
| (<<) CDKN2A → NEUROG1 |
| (<<) NKX3-2 → NEUROG1 |
| (<<) NPAS2 → NEUROG1 |
| (<<) FOSL1 → NEUROG1 |
| (<<) EVX1 → NEUROG1 |
| (<<) SPIB → NEUROG1 |
| (<<) ZNF165 → NEUROG1 |
| (<<) FOXP3 → NEUROG1 |
| (<<) SREBF1 → NEUROG1 |
| Downstream (Children) |
|---|
| NEUROG1 → GATA3 (>>) |
| NEUROG1 → GLI2 (>>) |
| NEUROG1 → TBX1 (>>) |
| NEUROG1 → TAF4 (>>) |
| NEUROG1 → POU4F3 (>>) |
| NEUROG1 → TP63 (>>) |
| NEUROG1 → POU4F2 (>>) |
| NEUROG1 → SNAPC5 (>>) |
| NEUROG1 → ZNF639 (>>) |
| NEUROG1 → CREBBP (>>) |
| NEUROG1 → LHX3 (>>) |
| NEUROG1 → BUD31 (>>) |
| NEUROG1 → ZNF134 (>>) |
